Live Breaking News & Updates on Daiichi Sankyo Eli Lilly

Stay updated with breaking news from Daiichi sankyo eli lilly. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Treating atrial high-rate episodes with edoxaban not effective, may be harmful

Treating atrial high-rate episodes with edoxaban not effective, may be harmful
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Germany , Amsterdam , Noord-holland , Netherlands , Hamburg , United-kingdom , Richard-smith , Daiichi-sankyo-europe , Daiichi-sankyo-eli-lilly , Daiichi-sankyo , Paulus-kirchhof , Byerik-swain

Mirvetuximab soravtansine data 'practice changing' for subset of women with ovarian cancer

CHICAGO — Mirvetuximab soravtansine-gynx extended survival of women with platinum-resistant ovarian cancer and high folate receptor-alpha expression, according to a study that compared the agent with investigator’s choice of chemotherapy.The antibody and microtubule inhibitor conjugate is the first novel therapy to show a survival benefit in a randomized phase 3 study among this ....

Chicago , Illinois , United-states , Kathleenn-moore , Bydevin-mclaughlin , Daiichi-sankyo-eli-lilly , Maurie-markman , Iovance-biotherapeutics , Mindy-valcarcel , Genentech-roche , Genentech , Astrazeneca

Add PCSK9 Inhibitors to Statins at Primary PCI: EPIC-STEMI

The powerful LDL-lowering agents aren t being used to their fullest potential, but giving them early to STEMI patients along with high-intensity statins would help amend that, researchers say. ....

Boston , Massachusetts , United-states , New-york , Canada , Toronto , Ontario , Sunnybrook , Alberta , Shamirr-mehta , Erica-cohen , Daiichi-sankyo-eli-lilly

Legacy of Neutral SYMPLICITY HTN-3 Recast by Long-term Outcomes

Although interest in renal denervation in hypertension fell off after disappointing results from the 2014 trial, a new, longer-term analysis argues the treatment may have worked after all. ....

New-york , United-states , Boston , Massachusetts , American , Naomi-fisher , Daiichi-sankyo-eli-lilly , Deepakl-bhatt , Roxana-mehran , Medscape-web , Insel-gruppe , Bristol-myers-squibb

QFR-Guided PCI Benefits Build Over Time: FAVOR III China

The sham-controlled study found clinical outcomes improved incrementally over time, compared with PCI guided by angiographic assessment of lesions. ....

Boston , Massachusetts , United-states , Beijing , China , Italy , Toronto , Ontario , Canada , Peking , Sunnybrook , Alberta